发明公开
- 专利标题： Antitumor antibiotic BU-3285T
- 专利标题（中）： 抗生素BU-3285T
-
申请号： EP90307579.4申请日： 1990-07-11
-
公开(公告)号： EP0408336A3公开(公告)日： 1991-04-03
- 发明人: Ohkuma, Hiroaki , Tomita, Koji , Konishi, Masataka , Kamei, Hideo
- 申请人： Bristol-Myers Squibb Company
- 申请人地址： 345 Park Avenue New York, N.Y. 10154 US
- 专利权人： Bristol-Myers Squibb Company
- 当前专利权人： Bristol-Myers Squibb Company
- 当前专利权人地址： 345 Park Avenue New York, N.Y. 10154 US
- 代理机构： Jones, Alan John
- 优先权： US378677 19890712; US431423 19891103
- 主分类号： C07D309/32
- IPC分类号： C07D309/32 ; C12P17/06 ; C12N1/20 ; A61K31/35
摘要：
The present invention relates to the antitumor antibiotic compound BU-3285T and its preparation. The compound is obtained by culturing a new strain of Chainia rosea and demonstrates both antitumor and antifungal activity. It also relates to the desulfated derivative of BU-3285T which is obtained by treatment of BU-3285T with sulfatase enzyme. BU-3285T desulfate possesses antitumor activity.
公开/授权文献
- EP0408336B1 Antitumor antibiotic BU-3285T 公开/授权日：1994-09-07
信息查询
